Venostent, Inc.

Publicly observed

Houston, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

Item	Value	Source	Status
Country	US	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
City / locality	Houston	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
Name	Venostent, Inc.	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
UEI (U.S. federal entity ID)	WLHLGMAJEAQ3	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed

Grant15 Sept 2026Publicly observed
NIH SBIR/STTR award: Process Validation and Commercialization of SelfWrap, a Bioabsorbable Wrap to Improve Dialysis Access Outcomes
USD 500,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Pilot-Scale Synthesis for the Commercialization of a Novel, Bioabsorbable Perivascular Wrap to Improve Outcomes in Arteriovenous Fistula Creation and Other Vascular Surgeries
USD 1,016,974.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Grant15 Apr 2020Publicly observed
NIH SBIR/STTR award: SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS
USD 1,212,392.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Grant15 Apr 2020Publicly observed
NIH SBIR/STTR award: TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS
USD 50,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Grant15 Apr 2020Publicly observed
NIH SBIR/STTR award: SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS
USD 1,212,392.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.